*ECULIZUMAB-VANCE — PEDIATRIC INVESTIGATIONAL UNIT 44-B.*
*RESTRICTED COMPASSIONATE USE ONLY.*
Grace stepped forward, her hand reaching out instinctively, her fingers trembling.
“Yes.
Please.
Give it to her.”
“Wait,” Dr.
Patel said.
She turned to a digital tablet mounted on the mobile workstation.
“The Lurie electronic medical portal just received a hard stop from the central institutional review board.
It was entered at eight-fifteen this morning by the managing trustee of the donor foundation.”
Dr.
Patel looked directly at Evelyn Carter.
“Mrs.
Carter,” the doctor said, her tone hardening into that unmistakable, ferocious protectiveness unique to pediatric intensivists.
“Are you the representative of the Carter-Vance Foundation who placed an experimental withdrawal on this unit?”
Evelyn didn’t blink.
The terror that had shaken her two minutes earlier seemed to retreat behind a wall of cold, desperate malice.
She reached down, picked up the velvet ring box from the floor, and placed it inside her camelhair pocket.
“The foundation,” Evelyn said, looking directly at me, “is currently conducting an internal regulatory audit regarding eligibility compliance for non-dependent recipients.
As the managing trustee, I have temporarily suspended the release of all un-blinded clinical units pending legal review.”
“She is three years old!”
Dr.
Patel yelled, completely discarding her clinical neutrality.
“Her platelets are at nine thousand!
If she develops a spontaneous intracranial bleed, she will be brain-dead before midnight!”
“Then I suggest,” Evelyn replied, her voice smooth as oil over deep water, “that her father remember his responsibilities to the family that pays for this hospital’s oncology wing.”
She looked at me—one last, terrible, predatory stare.
“You have thirty minutes, Ryan.
The dinner at the Drake is still waiting.
Harold Brooks is still at the table.
If you walk into that dining room, take your seat beside Amelia, and sign the merger proxy before ten o’clock, the clinical audit will be resolved by telephone.
The vial will be cleared.”
She stepped out into the corridor.
“If not,” she added over her shoulder, “you can see how much your bridge-builder ideals are worth when the morgue attendant arrives.”
“You monster,” Grace screamed, lunging toward the door, but I caught her by the waist, pulling her back against my chest as the two security guards stepped between us and my mother, closing the heavy fire door behind them with a definitive, mechanical latch.
***
V.
The True Lineage
The silence that returned to Room 412 was deafening.
Dr.
Patel stood with her hands on her hips, her scrub cap askew, looking at the refrigerated vial sitting inside the open caddy.
“Is there an alternative?”
I demanded, my hands shaking as I held Grace’s shivering shoulders.
“Another hospital?
Cleveland Clinic?
Johns Hopkins?
I can charter a medical jet within fifteen minutes!
I have three million dollars in personal liquidity in my private account—”
“There is no alternative within five hundred miles, Mr.
Carter,” Dr.
Patel said grimly.
“This is an orphan trial.
Carter-Vance holds the only FDA importation license for the raw peptide chain.
If we fly her at this platelet level, the cabin pressure drop could trigger a pulmonary hemorrhage before you reach Ohio.”
She looked down at the tablet.
“The only legal bypass to a foundation trustee hold under Illinois health codes is an immediate, direct biological match for an emergency bone marrow harvest.
An autologous transplant or an immediate full-haplotype parent match who can undergo a direct granulocyte and platelet pheresis down in the blood bank right now.”
Grace looked up, her face white.
“I was tested six months ago.
My human leukocyte antigen profile only matched three of Maya’s ten genetic markers.
The doctors said my marrow would cause an immediate graft-versus-host rejection.”
“What about me?”
I stepped forward, rolling up the sleeve of my dress shirt.
“Test me.
I’m her father.
Take whatever you need.
Marrow, blood, platelets—take it right now.”
Dr.
Patel looked at me with a strange, hesitant expression.
She didn’t reach for a tourniquet.
She walked over to the mobile workstation, tapped through several encrypted menus, and pulled up a historical laboratory file from the Northwestern Memorial health system, dated four years ago.
“Mr.
Carter,” Dr.
Patel said quietly.
“When you were admitted to Northwestern for emergency abdominal surgery following your car accident on Lake Shore Drive in 2022… do you remember having a full genetic panel run as part of your pre-operative profile?”
I frowned, my mind struggling to bridge the gap between that distant winter and this fluorescent nightmare.
“I…
I suppose so.
The insurance company required a pre-transfusion screen.”
“I pulled that record twenty minutes ago when your name was entered as the private guarantor at the front desk,” Dr.
Patel said.
